Francisco J Salguero Selected Research

Francisco J Salguero Research Topics

Disease

36	Infections 04/2024 - 05/2004
12	COVID-19 01/2023 - 10/2020
9	Tuberculosis (Tuberculoses) 01/2023 - 07/2011
6	Human Influenza (Influenza) 04/2023 - 01/2018
6	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2021 - 07/2009
5	Necrosis 02/2023 - 02/2013
4	Prion Diseases (Transmissible Spongiform Encephalopathies) 11/2006 - 01/2004
3	Weight Loss (Weight Reduction) 01/2023 - 01/2020
3	Granuloma 01/2023 - 07/2011
3	Melioidosis 12/2017 - 07/2011
2	Disease Progression 01/2023 - 01/2021
2	Coinfection 08/2021 - 01/2021
2	Neoplasms (Cancer) 01/2018 - 10/2013
2	Hepatitis 10/2015 - 04/2013
2	Bovine Spongiform Encephalopathy (Mad Cow Disease) 01/2006 - 05/2004
1	Buruli Ulcer 02/2023
1	Vaccinia 02/2023
1	Venezuelan Equine Encephalomyelitis 01/2023
1	Inflammation (Inflammations) 01/2023
1	Hypoxia (Hypoxemia) 01/2022
1	Pneumonia (Pneumonitis) 01/2021
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2021
1	Bovine Tuberculosis 01/2021
1	Severe Acute Respiratory Syndrome 01/2021
1	Hantavirus Infections 10/2020
1	Critical Illness (Critically Ill) 10/2019
1	Cognitive Dysfunction 01/2018
1	Carcinogenesis 01/2018
1	Non-alcoholic Fatty Liver Disease 01/2018
1	Latent Infection 01/2018
1	Orthomyxoviridae Infections 10/2016
1	Fibrosis (Cirrhosis) 10/2015
1	Edema (Dropsy) 10/2015
1	Visceral Leishmaniasis (Kala Azar) 09/2015
1	Leishmaniasis 09/2015
1	Foot-and-Mouth Disease 11/2014

Drug/Important Bio-Agent (IBA)

24	VaccinesIBA 04/2023 - 02/2013
9	CytokinesIBA 04/2024 - 07/2009
8	Proteins (Proteins, Gene)FDA Link 10/2023 - 10/2006
6	AerosolsIBA 08/2021 - 01/2012
4	EnzymesIBA 01/2020 - 04/2013
4	Prion ProteinsIBA 11/2006 - 05/2004
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2018
3	Interleukin-10 (Interleukin 10)IBA 10/2015 - 07/2009
3	Interferon-gamma (Interferon, gamma)IBA 10/2014 - 07/2009
2	AcidsIBA 01/2023 - 12/2020
2	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2022 - 01/2018
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2018
2	DNA VaccinesIBA 01/2021 - 09/2015
2	Monoclonal AntibodiesIBA 01/2021 - 01/2006
2	Interferon Type IIBA 01/2021 - 10/2014
2	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2018
2	Interleukin-6 (Interleukin 6)IBA 03/2017 - 07/2011
2	CollagenIBA 10/2015 - 07/2011
1	Messenger RNA (mRNA)IBA 04/2024
1	Interleukin-23 (Interleukin 23)IBA 04/2024
1	NucleotidesIBA 10/2023
1	Amino Acids FDA Link 10/2023
1	mycolactoneIBA 02/2023
1	ExotoxinsIBA 02/2023
1	Neuraminidase (Sialidase)IBA 02/2023
1	NucleoproteinsIBA 02/2023
1	Nasal SpraysIBA 02/2023
1	ChemokinesIBA 01/2023
1	N-(2-cyanoethylene)urea (BA 1)IBA 01/2023
1	COVID-19 VaccinesIBA 07/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	Subgenomic RNAIBA 01/2022
1	reluscovtogene ralaplasmidIBA 01/2021
1	ChAdOx1 nCoV-19IBA 01/2021
1	EpitopesIBA 01/2021
1	Immune Sera (Antisera)IBA 01/2021
1	Single-Domain AntibodiesIBA 01/2021
1	Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA 10/2020
1	Immunoglobulin A (IgA)IBA 11/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2019
1	Caspase 3 (Caspase-3)IBA 01/2019
1	InterferonsIBA 01/2019
1	AntigensIBA 01/2019
1	Peptides (Polypeptides)IBA 01/2018
1	Tuberculin (PPD)IBA 01/2018
1	Tumor Viral Antigens (Large T Antigen)IBA 01/2018
1	Advanced Glycation End ProductsIBA 01/2018
1	Neutralizing AntibodiesIBA 01/2018
1	ImmunosorbentsIBA 01/2018
1	Pyruvaldehyde (Methylglyoxal)IBA 01/2018
1	imidazoloneIBA 01/2018
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2018
1	LipidsIBA 01/2017
1	Metalloproteases (Metalloproteinases)IBA 10/2015
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 09/2015
1	liposomal amphotericin B FDA Link 09/2015
1	Immunologic Factors (Immunomodulators)IBA 09/2015
1	Attenuated VaccinesIBA 04/2015

Therapy/Procedure

12	Therapeutics 04/2023 - 04/2013
1	Immunomodulation 04/2024
1	Lasers (Laser) 04/2024
1	Intranasal Administration 01/2021
1	Aftercare (After-Treatment) 01/2019
1	Immunotherapy 09/2015